Dr Tari Haahtela, Head of the Skin and Allergy Hospital, advises us to improve our resistance to allergens by re-establishment of our contact with the nature. Anssi Koivuranta, a Finnish Olympic athlete, gets along with his asthma. Pick useful advice on allergies from OrionNOW, here »
Learn more>>
Altogether 300,000 own B-shares were repurchased by Orion during 11-18 August. Altogether 514,424 own B-shares are now held by the company. Read more about treasury shares here>>
Orion Corporation and Selvita, a Polish biotechnology company, have agreed to collaborate on further research and development of Selvita’s SEL103 program, for the symptomatic treatment of Alzheimer’s disease. Learn more >>
Fermion is initiating a major plant expansion project at its Oulu site towards the end of 2010. The new facilities are planned to be operational in early 2012. Read more>>
Sustainability is a new section added to our corporate website. As the main component under it, Orion provides its first Sustainability Report, in the form of a web publication. Based on the recommendations of the GRI (Global Reporting Initiative), our performance is reviewed from the aspects of Financial, Environmental and Social responsibility.
Read about Orion's approaches to responsibility here>>
The QuikRead® CRP test helps the healthcare practitioner to differentiate between bacterial and viral infection and gives guidance on antibiotic use.Read more »